CLIFFORD Hallam Healthcare (CH2) has been appointed as a Community Service Obligation (CSO) Distributor, with the move effective 01 Jan (PD breaking news).
Company ceo David Collins said that with community pharmacy being a critical link in a complex health care network, "it was important for CH2 to be able to support all areas of pharmacy and so CSO appointment was essential".
CH2's existing national footprint sees the company service public and private hospitals, medical centres, specialists, day surgeries, diagnostic imaging, pathologists, dentists, government bodies as well as hospital & community pharmacy.
Collins said his team had extensive experience within the pharmacy market and had been working behind the scenes over the last few months to extend the CH2 range to cover CSO product lines.
CH2 will share the CSO funding pool with existing national distributors API, Sigma & Symbion as well as SA's National Pharmacies.
The above article was sent to subscribers in Pharmacy Daily's issue from 22 Dec 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 22 Dec 16